Israel - English - Ministry of Health

bioavenir ltd, israel - clodronic acid as disodium tetrathydrate - film coated tablets - clodronic acid as disodium tetrathydrate 800 mg - clodronic acid - treatment of hypercalcemia due to malignancy. palliative treatment of osteolysis due to malignancy.

Israel - English - Ministry of Health

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 10 mg; naloxone hydrochloride (as dihydrate) 5 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Israel - English - Ministry of Health

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 20 mg; naloxone hydrochloride (as dihydrate) 10 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Israel - English - Ministry of Health

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 30 mg; naloxone hydrochloride (as dihydrate) 15 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Israel - English - Ministry of Health

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 40 mg; naloxone hydrochloride (as dihydrate) 20 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Israel - English - Ministry of Health

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 5 mg; naloxone hydrochloride (as dihydrate) 2.5 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Israel - English - Ministry of Health

bioavenir ltd, israel - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - abivenir is a cyp17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).

Israel - English - Ministry of Health

bioavenir ltd, israel - finasteride - film coated tablets - finasteride 1 mg - finasteride - finasteride - proavenir is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.

Israel - English - Ministry of Health

bioavenir ltd, israel - finasteride - film coated tablets - finasteride 1 mg - finasteride - proavenir is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.

Israel - English - Ministry of Health

bioavenir ltd, israel - fulvestrant - solution for injection - fulvestrant 50 mg/ml - fulvestrant - monotherapy :fulvenir is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:not previously treated with endocrine therapy, or with disease relapse on or after adjuvant endocrine therapy; or disease progression on endocrine therapy. combination therapy with palbociclib: fulvenir is indicated for the treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.